The uncertainty of MAP2K4's role in regulating human prostate cancer metastasis is further increased by studies across several different cancer types which support either a metastasis suppressor [6], [7], [19]–[21], or stimulatory role [9], [11], [17], [18]. Here, MAP2K4 is linked to prostate carcinoma.